Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine

Clinical trial NCT07418372 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07418372
Sponsor: Institute of Medical Biology, Chinese Academy of Medical Sciences
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Tetanus, Diphtheria and Acellular Pertussis Vaccination Tetanus Diphtheria Pertussis Pertussis Vaccines

Start date: 2026-03-12
Primary completion: 2026-08-31
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.